Ortho Biotech Products, L.P.

41 articles about Ortho Biotech Products, L.P.

• Ortho Biotech Products, L.P. Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer

  12/15/2008

• Ortho Biotech Products, L.P. Announces NDA Submission for Trabectedin for the Treatment of Relapsed Ovarian Cancer

  11/20/2008

• Ortho Biotech Products, L.P. Release: Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting

  11/7/2008

• Ortho Biotech Products, L.P. Preliminary Data From Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa

  9/18/2008

• Ortho Biotech Products, L.P. Files sNDA for DOXIL(R) for the Treatment of Advanced Breast Cancer

  9/8/2008

• Janssen-Cilag International NV, Ortho Biotech Products, L.P. VELCADE(R) Approved For Previously Untreated Multiple Myeloma

  9/8/2008

• Ortho Biotech Products, L.P. Announces Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot Number P114942A

  8/6/2008

• Ortho Biotech Products, L.P. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology Annual Meeting

  5/30/2008

• Ortho Biotech Products, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product

  5/16/2008

• Ortho Biotech Products, L.P. Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets

  4/11/2008

• Data From Ortho Biotech Products, L.P. Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings

  4/7/2008

• Ortho Biotech Products, L.P. Statement on FDA Oncologic Drugs Advisory Committee Vote

  3/14/2008

• Ortho Biotech Products, L.P. Release: Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia

  3/11/2008

• Ortho Biotech Products, L.P. Modifies Prescribing Information for PROCRIT(R)

  3/10/2008

• Ortho Biotech Products, L.P. Statement On JAMA Publication Regarding Erythropoiesis

  2/27/2008

• Ortho Biotech Products, L.P. Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents

  2/1/2008

• Ortho Biotech Products, L.P. Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia

  12/11/2007

• Ortho Biotech Products, L.P. Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting

  12/10/2007

• Ortho Biotech Products, L.P. PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting

  12/6/2007

• Ortho Biotech Products, L.P. Updated Analysis of 2001 Epoetin Alfa Study Posted

  12/5/2007